Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Jefferies London Healthcare Conference 2025 November 19, 2025 4:30 AM ESTCompany ParticipantsTony Wood - Chief Scientific Officer and Head ...

CoapTech, a medical technology company advancing ultrasound?guided solutions for enteral access, today announced that its Board of Directors has appointed Brad Kreger as Chief Executive Officer.

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...

Medicaid provides health coverage for disabled and low-income populations, and the ACA expansion gives states the option to extend coverage to adults with up to 138% of the federal poverty line.

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

An injectable form of HIV pre-exposure prophylaxis (PrEP) developed by GSK's ViiV Healthcare unit will be offered by the NHS in England and Wales, ending a disparity in access within the UK.

The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

Global 3D scanning leader Artec 3D has launched a new, accessible version of its software, Artec Studio Lite. Designed to make Artec Studio's professional 3D tools available to a larger audience, ...

The Bay Area Reporter reports that Delta Air Lines isn’t covering long-acting injectable PrEP, or the oral PrEP drug Descovy, ...

Fiji Rugby’s elevation into the new Nations Championship is expected to transform the organisation’s competitive standing and ...